Par Pharmaceutical Companies, Inc. (NYSE:PRX)
CAPS Rating:
The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.
RSS Headlines
Fool UK
Recs
Like their cash to debt ratio